Stocksigma LogoStocksigma Logo

Piramal Pharma Board to Consider Q2 Results on 27th Oct'26

Piramal Pharma Limited announced that its Board of Directors will meet on 27th Oct'26 to consider and approve the standalone and consolidated unaudited

Piramal Pharma Board to Consider Q2 Results on 27th Oct'26

Piramal Pharma Ltd 路 Intimation 路 27 Oct 2026, 5:30 am

Piramal Pharma Board to Consider Q2 Results on 27th Oct'26 Piramal Pharma Limited announced that its Board of Directors will meet on 27th Oct'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. Additionally, the trading window for dealing in company securities, which closed on 1st Oct'26, will remain shut until 29th Oct'26 (both days inclusive) in compliance with SEBI listing regulations.

Original exchange filing (PDF)

More announcements from Piramal Pharma Ltd

All Piramal Pharma Ltd announcements